funding in pharma

As per data provided by Tracxn, the decline in investment activity makes February 2025 one of the lowest-funded months in the past…

INR 1600 crore fund to invest in early to growth stage companies across the Life Science and Healthcare Segment

Exsure is a biotech startup working to reduce the side effects and toxicity of anti-cancer drugs by its patented exosomal…

Beta Drugs offers a broad product portfolio across major oncology segments, including chemotherapy, targeted, hormonal and…

As per Traxcn.com funding falls 45 per cent from $346 million in August 2024